New Leukemia Treatment By Amgen To Cost $178,000

December 18, 2014 7:05 AM

4 0

A new leukemia drug, Blincyto, will cost $178,000 for one course of treatment. The drug, manufactured by Amgen Inc., will continue the trend of high prices among immunotherapy drugs.

A new leukemia drug, Blincyto, will cost $178,000 for one course of treatment. The drug, manufactured by Amgen Inc., will continue the trend of high prices among immunotherapy drugs.

Read more

To category page

Loading...